How many clinical trials are tracked for Cushing's Disease?

10 trials are tracked, 5 with published results.

Mode

All Infectious Disease Oncology Neurology Cardiology Psychiatry Diabetes & Endocrinology Pediatrics Allergy & Immunology Rheumatology Gastroenterology Primary Care & Family Medicine Nutrition & Obesity Medicine OB/GYN & Women's Health Orthopedics & Sports Medicine Genetics & Precision Medicine Radiology & Imaging Pulmonology & Critical Care Anesthesiology & Pain Medicine Physical Medicine & Rehab Nephrology Hematology Ophthalmology Urology Dermatology Emergency Medicine Geriatrics & Aging ENT (Otolaryngology) Palliative Care

Research

Clinical Trials Drug Pipeline Weekly Digests

Reference

Conditions Medications

Community

Questions

Text Size

Cushing's Disease

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials for Cushing's Disease

10 trials tracked for Cushing's Disease: 8 in phase 3 or 4 and 5 with published results. The most-cited published study has 165 citations.

10Trials tracked

8Phase 3 & 4

0Recruiting

5With published results

Phase distribution

Phase 4 2 Phase 3 6 Phase 2 1 Other / NA 1

Phase 3 Efficacy and Safety of Pasireotide Administered Monthly in Patients With Cushing's Disease Completed · 165 cited
Phase 3 Efficacy and Safety Evaluation of Osilodrostat in Cushing's Disease Completed · 107 cited
Phase 4 Study of Management of Pasireotide-induced Hyperglycemia in Adult Patients With Cushing's Disease or Acromegaly Completed · 80 cited
Phase 3 Safety and Efficacy of LCI699 for the Treatment of Patients With Cushing's Disease Completed · 41 cited
Phase 3 An Open-label, Multi-center, Expanded Access Study of Pasireotide s.c. in Patients With Cushing's Disease. Completed · 17 cited
Phase 4 Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in Novartis-sponsored Studies Completed

Show 4 more trials

Phase 3 Safety and Efficacy of Different Dose Levels of Pasireotide in Patients With de Novo, Persistent or Recurrent Cushing's Disease Completed
Phase 3 Compassionate Use of CORLUX® (Mifepristone) in the Treatment of Signs and Symptoms of Endogenous Cushing's Syndrome Completed
Phase 2 Safety and Efficacy of LCI699 in Cushing's Disease Patients Completed
N/A Long Term Safety and Efficacy of Pasireotide s.c. in Patients With Cushing's Disease Completed

Showing the 10 most-cited and recently-updated of 10 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.